Literature DB >> 24631344

Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase.

Jingfei Zhang1, Aqsa Malik1, Hyun B Choi1, Rebecca W Y Ko1, Lasse Dissing-Olesen1, Brian A MacVicar2.   

Abstract

Complement receptor 3 (CR3) activation in microglia is involved in neuroinflammation-related brain disorders and pruning of neuronal synapses. Hypoxia, often observed together with neuroinflammation in brain trauma, stroke, and neurodegenerative diseases, is thought to exacerbate inflammatory responses and synergistically enhance brain damage. Here we show that when hypoxia and an inflammatory stimulus (lipopolysaccharide [LPS]) are combined, they act synergistically to trigger long-term synaptic depression (LTD) that requires microglial CR3, activation of nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), and GluA2-mediated A-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) internalization. Microglial CR3-triggered LTD is independent of N-methyl-D-aspartate receptors (NMDARs), metabotropic glutamate receptors (mGluRs), or patterned synaptic activity. This type of LTD may contribute to memory impairments and synaptic disruptions in neuroinflammation-related brain disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24631344     DOI: 10.1016/j.neuron.2014.01.043

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  82 in total

Review 1.  Microglia antioxidant systems and redox signalling.

Authors:  F Vilhardt; J Haslund-Vinding; V Jaquet; G McBean
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 2.  A decade of diverse microglial-neuronal physical interactions in the brain (2008-2018).

Authors:  Joseph O Uweru; Ukpong B Eyo
Journal:  Neurosci Lett       Date:  2019-01-06       Impact factor: 3.046

Review 3.  Glial Regulation of the Neuronal Connectome through Local and Long-Distant Communication.

Authors:  R Douglas Fields; Dong Ho Woo; Peter J Basser
Journal:  Neuron       Date:  2015-04-22       Impact factor: 17.173

4.  Tumor necrosis factor-α potentiates long-term potentiation in the rat dentate gyrus after acute hypoxia.

Authors:  Audrey M Wall; Gatambwa Mukandala; Nigel H Greig; John J O'Connor
Journal:  J Neurosci Res       Date:  2015-01-12       Impact factor: 4.164

Review 5.  Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?

Authors:  Yuetiva Deming; Zeran Li; Bruno A Benitez; Carlos Cruchaga
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

Review 6.  The role of microglia in chronic pain and depression: innocent bystander or culprit?

Authors:  Nan Yin; Enshi Yan; Wenbin Duan; Changyuan Mao; Qin Fei; Chun Yang; Yimin Hu; Xiaolin Xu
Journal:  Psychopharmacology (Berl)       Date:  2021-02-05       Impact factor: 4.530

Review 7.  Astrocyte regulation of blood flow in the brain.

Authors:  Brian A MacVicar; Eric A Newman
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-03-27       Impact factor: 10.005

8.  'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared.

Authors:  Michaela D Filiou; Ahmed Shamsul Arefin; Pablo Moscato; Manuel B Graeber
Journal:  Neurogenetics       Date:  2014-06-15       Impact factor: 2.660

9.  Nonsteroidal anti-inflammatory drug, indomethacin improves spatial memory and NMDA receptor function in aged animals.

Authors:  Ashok Kumar; Asha Rani; Rachel B Scheinert; Brandi K Ormerod; Thomas C Foster
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

10.  RAGE inhibition in microglia prevents ischemia-dependent synaptic dysfunction in an amyloid-enriched environment.

Authors:  Nicola Origlia; Chiara Criscuolo; Ottavio Arancio; Shirley ShiDu Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2014-06-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.